Huang Xin, Wu Yanyan, Ni Yulu, Xu Haiyan, He Yinhui
Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Municipal Central Hospital, Lishui, China.
Front Public Health. 2025 Jan 23;13:1515797. doi: 10.3389/fpubh.2025.1515797. eCollection 2025.
To produce estimates of the global burden of type 2 diabetes mellitus (T2DM) caused by high body mass index (high BMI) and its impact for 2021 and projections for 2045.
We downloaded data from the Global Burden of Disease Study 2021(GBD 2021) to estimate the disease burden of T2DM caused by high BMI. Secondary analyses were performed by year, age, gender, region, and socio-demographic index (SDI).
Globally, the all-ages number of T2DM-related deaths has increased significantly from 238.1 thousand to 723.7 thousand, representing a 203.9% increase since 1990. And the all-ages number of T2DM-raleted DALYs has raised from 10.4 million to 39.3 million, increased by 276.7% from 1990. The burden was expected to continue to increase to 1296.7 thousand by 2045 for all-ages number of deaths, and 85.5 million by 2045 for all-ages number of DALYs. The curves of T2DM-related burden showed an intersection for different genders around the age of 60, beyond which women exhibit a higher burden, compared to men. The disease burden of T2DM caused by high BMI shows a significant upward trend across all SDI groups, with a heavier burden on women, especially in the postmenopausal female population. In 2021, among the 204 countries and territories, the top 3 largest number of T2DM-related burden caused by high BMI occurred in China, India, and United States. The top three countries with highest T2DM-related rate caused by high BMI were Fiji, Marshall Islands, and Kiribati.
Our study reveals that the disease burden of T2DM caused by high BMI is significantly increasing and is expected to continue rising in the future. Women bear a heavier burden, particularly postmenopausal women, and there are significant differences in the disease burden across different geographical regions, and socioeconomic statuses. Targeted considerations and specific strategies are essential to address these disparities, thereby improving public health and reducing the burden.
对2021年由高体重指数(高BMI)导致的2型糖尿病(T2DM)全球疾病负担及其影响进行评估,并对2045年进行预测。
我们从《2021年全球疾病负担研究》(GBD 2021)下载数据,以估算高BMI导致的T2DM疾病负担。按年份、年龄、性别、地区和社会人口指数(SDI)进行二次分析。
在全球范围内,与T2DM相关的全年龄段死亡人数从23.81万显著增加到72.37万,自1990年以来增长了203.9%。与T2DM相关的全年龄段伤残调整生命年(DALYs)从1040万增加到3930万,自1990年以来增长了276.7%。预计到2045年,全年龄段死亡人数将继续增加到129.67万,全年龄段DALYs将增加到8550万。与T2DM相关的负担曲线在60岁左右的不同性别之间出现交叉,超过该年龄后,女性的负担高于男性。高BMI导致的T2DM疾病负担在所有SDI组中均呈显著上升趋势,女性负担更重,尤其是绝经后女性人群。2021年,在204个国家和地区中,高BMI导致的T2DM相关负担数量最多的前三个国家是中国、印度和美国。高BMI导致的T2DM相关发病率最高的前三个国家是斐济、马绍尔群岛和基里巴斯。
我们的研究表明,高BMI导致的T2DM疾病负担正在显著增加,预计未来还将继续上升。女性负担更重,尤其是绝经后女性,不同地理区域和社会经济状况的疾病负担存在显著差异。针对这些差异进行有针对性的考虑和制定具体策略对于改善公众健康和减轻负担至关重要。